Vitamin D after 40: what the evidence supports

The short answer: vitamin D matters, and most of what it was sold for did not hold up. Correcting a genuine deficiency has been shown to improve bone health and muscle function. Supplementing people who already have adequate levels has, in large randomized trials, produced little for cancer, cardiovascular disease, or fractures. The honest position after 40: a modest daily dose (typically 600–2,000 IU) is cheap, safe, and reasonable insurance — but it is insurance, not treatment for anything you don’t have.

What it is

Vitamin D is a fat-soluble hormone precursor. Your skin makes it from UVB sunlight; a small amount comes from food — oily fish, egg yolks, and fortified milk and cereals are the main dietary sources, and none of them are abundant. The liver converts it to 25-hydroxyvitamin D, or 25(OH)D, which is the form measured in blood tests, and the kidneys convert that to the active hormone.

Its best-established job is calcium absorption. Without enough vitamin D, you absorb only a fraction of the calcium you eat, and the body pulls calcium from bone to keep blood levels stable. Severe, prolonged deficiency causes rickets in children and osteomalacia — soft, painful bones — in adults. That relationship is not in dispute, and it is the reason vitamin D matters at all.

What happened over the last two decades is that observational studies kept finding low vitamin D levels alongside nearly every disease of aging: heart disease, cancer, diabetes, depression, dementia, infection. The reasonable hypothesis was that low vitamin D contributed. The trials that followed mostly found the arrow pointing the other way — illness, inactivity, and time indoors lower vitamin D, rather than the reverse.

Where the thresholds actually fall

Blood 25(OH)D is reported in two units, which causes endless confusion:

Status	ng/mL	nmol/L
Deficient	under 12	under 30
Potentially inadequate	12–20	30–50
Adequate for most people	20 and above	50 and above
No added benefit above	~50	~125

Two things are worth noticing. First, “adequate” starts lower than most supplement marketing implies — 20 ng/mL, not 40 or 50. Second, there is a top end. Consistently high levels are not better, and above roughly 125 nmol/L (50 ng/mL) the potential for harm begins to be discussed rather than benefit.

The reference intakes: 600 IU (15 mcg) per day for adults up to 70, and 800 IU (20 mcg) from 71, with a tolerable upper intake level of 4,000 IU (100 mcg) per day from supplements. The NHS takes a different practical approach for a cloudier country, recommending 400 IU (10 mcg) daily for everyone during autumn and winter.

What the evidence shows, graded

Has been shown to:

• Correct deficiency and reverse osteomalacia. This is the core, undisputed use.
• Improve calcium absorption. Vitamin D is a prerequisite for getting calcium out of your diet and into bone.
• Reduce fracture and fall risk in deficient or institutionalized older adults, particularly when combined with calcium. The qualifier is doing real work in that sentence — the benefit is concentrated in people who started low or live in residential care.
• Be safe at intakes up to 4,000 IU/day in healthy adults, across long follow-up.

Research suggests:

• Reduced incidence of autoimmune disease. A large randomized trial found a modest reduction in new autoimmune diagnoses over roughly five years with 2,000 IU/day. It is one of the more interesting positive findings, and it needs replication.
• A small effect on respiratory infection risk, mainly in people who were deficient at baseline. Daily dosing appears to matter more than total amount; large intermittent doses do not show the same signal.
• Some benefit for muscle strength and physical function in older adults who are deficient — again, the effect lives in the correction, not the topping up.

May help, evidence early or mixed:

• Cancer mortality (as distinct from cancer incidence, which large trials did not reduce). Some analyses hint at fewer deaths from cancer with daily supplementation; the finding is secondary and not confirmed.
• Type 2 diabetes prevention in people with prediabetes. Trials show at most a small effect, mostly in those with low baseline levels or lower body weight.
• Mood and depressive symptoms. Mixed and generally unimpressive in people without deficiency.

What the large trials did not find: Randomized trials enrolling tens of thousands of mostly vitamin-D-replete adults have not shown reductions in total cancer incidence, major cardiovascular events, total mortality, or — in generally healthy community-dwelling adults — fractures. This is the part the supplement aisle has not caught up with. It does not mean vitamin D is useless. It means that in people who already have enough, more does not appear to buy anything.

Who it may suit

The people most likely to benefit are the people most likely to be low:

• Anyone living above roughly 37° latitude (north of San Francisco, Athens, or Seoul) during autumn and winter, when UVB is too weak for skin synthesis regardless of how long you’re outside.
• People with darker skin. Higher melanin means substantially less vitamin D produced per unit of sun exposure.
• Adults over 65. Skin synthesis declines markedly with age — an older adult produces a fraction of what a young adult makes from identical exposure.
• People who are mostly indoors, cover their skin for cultural or medical reasons, or use sunscreen consistently.
• People with obesity. Vitamin D is fat-soluble and distributes into adipose tissue, so serum levels run lower at the same intake; higher doses are often needed.
• People with malabsorption conditions — celiac disease, Crohn’s, cystic fibrosis, or after bariatric surgery.
• People on medications that lower vitamin D status, including some anticonvulsants, glucocorticoids, and weight-loss or cholesterol drugs that interfere with fat absorption.

For most other adults over 40, a daily 1,000–2,000 IU is a defensible default: it comfortably covers the requirement, sits well under the upper limit, and costs a few cents a day. Take it with a meal containing some fat — absorption is meaningfully better than on an empty stomach.

On testing

Routine screening of healthy adults is not generally recommended, and a test you are going to respond to with “take 1,000 IU daily” was probably not worth running. Testing is genuinely useful if you have osteoporosis, a fracture from minor trauma, a malabsorption condition, unexplained bone or muscle pain, chronic kidney disease, or you fall into several risk categories at once. It’s also worth retesting after a few months if you were treated for a documented deficiency.

If you do test, ask for 25(OH)D — not the active form, 1,25-dihydroxyvitamin D, which is a different test that answers a different question and can look normal in someone frankly deficient.

Who should ask a clinician first

• Anyone with sarcoidosis, tuberculosis, or another granulomatous disease, or certain lymphomas. These conditions convert vitamin D to its active form outside normal regulation, and supplementation can cause dangerous hypercalcemia. This is the most important contraindication in the category.
• Anyone with chronic kidney disease or a history of kidney stones. Vitamin D handling changes with kidney function, and calcium metabolism needs supervision.
• Anyone with primary hyperparathyroidism or a history of high blood calcium.
• Anyone taking thiazide diuretics, which reduce calcium excretion — combined with vitamin D and calcium, the risk of hypercalcemia rises.
• Anyone taking digoxin, where high blood calcium can precipitate arrhythmia.
• Anyone considering high-dose or “loading” regimens. Weekly 50,000 IU protocols exist and are legitimate under supervision for documented deficiency. Very large intermittent doses given without deficiency have, in more than one trial, been associated with more falls and fractures rather than fewer.
• During pregnancy, where requirements and upper limits should be set with your clinician rather than from a bottle.

Toxicity is rare but real, and it comes almost entirely from supplements — never from sun. It generally requires sustained intakes far above the upper limit, with symptoms driven by high blood calcium: nausea, excessive thirst and urination, confusion, and eventually kidney damage.

What to look for in a product

Generic criteria only:

• Vitamin D3 (cholecalciferol) rather than D2 in most cases. D3 raises and maintains blood levels more effectively per unit. D2 is a reasonable vegetarian-source alternative, though lichen-derived D3 also exists.
• A dose you’d actually take daily, in the 1,000–2,000 IU range for general use. Bottles at 5,000 or 10,000 IU exist and are appropriate under supervision; they are not a sensible default.
• Units stated clearly in both IU and micrograms. 1,000 IU = 25 mcg. Labels that give only one make comparison harder than it needs to be.
• A third-party verification mark — USP, NSF, or an equivalent independent testing program. Vitamin D content in supplements has been found to vary from label claim, and independent testing is the only practical check.
• Softgels or drops in an oil base if you want the most reliable absorption, though the difference is smaller than it’s made to sound when taken with food.
• Skepticism about combination products. Vitamin D bundled with K2, magnesium, and a proprietary blend costs more and complicates dosing without clear added benefit.

What the marketing overstates

The immune claims. Vitamin D’s connection to immune function is real biologically, and the trial results for actual illness are modest at best. “Immune support” on a vitamin D bottle is doing more work as a phrase than the evidence supports.

The optimal-range inflation. A great deal of marketing — and some testing services — define “optimal” at 40–60 ng/mL, well above the 20 ng/mL that the evidence supports as adequate. Higher targets sell more product. They have not been shown to produce better outcomes.

The idea that vitamin D is why you’re tired. Fatigue has many causes and vitamin D deficiency is one of the less common ones in an otherwise healthy adult. It’s a cheap thing to rule out; it’s rarely the answer.

Megadose culture. The jump from 2,000 to 10,000 IU is presented as enthusiasm rather than a decision with a downside. Above the upper limit, you’re accepting real risk in exchange for benefits that trials have not demonstrated.

The bone shortcut. Vitamin D helps you absorb calcium. It does not build bone by itself. The interventions with the strongest evidence for bone density after 40 are resistance training and adequate protein and calcium — vitamin D makes those work, it doesn’t replace them.

When to talk to a clinician

Talk to your clinician if you have any of the conditions listed above, if you take thiazide diuretics or digoxin, if you’re on medications affecting fat absorption, or if you’re considering more than 4,000 IU a day.

Ask for testing rather than guessing if you have osteoporosis or a low-trauma fracture, persistent bone or muscle pain or weakness, a malabsorption condition, or several deficiency risk factors together.

And if you’ve been taking a high-dose product for a while without ever having your level checked, that’s a reasonable thing to raise at your next appointment — not because it’s likely to be harmful, but because you may be paying for a number you already have.